Worth reading
72In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
140000000
円（増資上限額）Wording
Conditional
How definitive the wording is.Agreements reached under this partnership
Joint venture7707Precision System Science Co.,Ltd.
Alliance partner嘉兴凯实生物科技股份有限公司（Quaero Life Science Co., Ltd）
Details of the alliance
- 1
日本製理化学検査機器及び装置、周辺デバイスの輸出促進
- 2
PSSグループの生産拠点における機器及び装置製造部門を軸とした、合弁会社化
- 3
NPSの増資をQuaero社が引き受ける
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Capital and personnel relationships
This indicates whether the companies will do more than work together, such as holding each other’s shares or seconding personnel (capital and business alliance).
51.00%Our ownership stake in the partner’s shares
Acquisition price上限1億4千万円の増資
Ownership ratioQuaero社 約51%、当社 約49%
Overview of the joint ventureName エヌピーエス株式会社（NPS） / Location Not disclosed / Business Description 理化学検査機器及び装置製造 / Capital Contributions 増資上限1億4千万円 / Ownership ratio Quaero社 約51%、当社 約49%
About the partner
Business Descriptionライフサイエンス向け試薬及び医療設備分野の技術開発、技術移転、技術サービス、技術コンサル。中国における第１類医療機器の研究開発、製造、修理メンテナンス。第２類と第３類6840臨床検査分析機器の研究開発、製造、修理メンテナンス。環境検査機器、光学分析機器、実験室自動化機器の製造、加工と開発。電子製品、機器設備（自動車を含まない）のメンテナンスサービス。輸出入業務。
Location中国・浙江省嘉興市南湖区大橋鎮
Share capital4,932.6923万RMB（約10億円）
Impact on Business Performance
The impact of this transaction on consolidated results for the current fiscal year is immaterial
Date of board resolution27 June 2025Contract Date27 June 2025Share Acquisition Date and Payment Date2025年9月30日を期限
| Item | Details |
|---|---|
| Name of alliance partner | 嘉兴凯实生物科技股份有限公司（Quaero Life Science Co., Ltd） |
| Alliance partner's business activities | ライフサイエンス向け試薬及び医療設備分野の技術開発、技術移転、技術サービス、技術コンサル。中国における第１類医療機器の研究開発、製造、修理メンテナンス。第２類と第３類6840臨床検査分析機器の研究開発、製造、修理メンテナンス。環境検査機器、光学分析機器、実験室自動化機器の製造、加工と開発。電子製品、機器設備（自動車を含まない）のメンテナンスサービス。輸出入業務。 |
| Alliance partner's location | 中国・浙江省嘉興市南湖区大橋鎮 |
| Alliance partner's capital | 4,932.6923万RMB（約10億円） |
| Type of alliance | Joint venture |
| Details of the alliance | 日本製理化学検査機器及び装置、周辺デバイスの輸出促進, PSSグループの生産拠点における機器及び装置製造部門を軸とした、合弁会社化, NPSの増資をQuaero社が引き受ける |
| Acquisition price | 上限1億4千万円の増資 |
| Shareholding ratio | Not disclosed → Quaero社 約51%、当社 約49% |
| Overview of the joint venture | Name エヌピーエス株式会社（NPS） / Location Not disclosed / Business Description 理化学検査機器及び装置製造 / Capital Contributions 増資上限1億4千万円 / Ownership ratio Quaero社 約51%、当社 約49% |
| Ownership ratio | Quaero社 約51%、当社 約49% |
| Date of board resolution | 27 June 2025 |
| Contract Date | 27 June 2025 |
| Share Acquisition Date and Payment Date | 2025年9月30日を期限 |
| Impact on Business Performance | The impact of this transaction on consolidated results for the current fiscal year is immaterial |
Items this document does not state (9)
Alliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyAlliance start dateChange in major shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.日本製の理化学検査機器・装置や周辺デバイスの輸出促進を図るため、PSSグループの機器・装置製造部門を軸に合弁会社化する。合弁化を契機に、電子部品やモジュール調達のさらなるコスト削減も検討する。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.